Literature DB >> 18302030

Advanced formulation design: improving drug therapies for the management of severe and chronic pain.

Dave A Miller1, James C Dinunzio, Robert O Williams.   

Abstract

Chronic pain is a condition affecting a vast patient population and resulting in billions of dollars in associated health care costs annually. Sufferers from severe chronic pain often require [correction of requite] twenty-four hour drug treatment through intrusive means and/or repeated oral dosing. Although the oral route of administration is most preferred, conventional immediate release oral dosage forms lead to inconvenient and suboptimal drug therapies for the treatment of chronic pain. Effective drug therapies for the management of chronic pain therefore require advanced formulation design to optimize the delivery of potent analgesic agents. Ideally, these advanced delivery systems provide efficacious pain therapy with minimal side effects via a simple and convenient dosing regime. In this article, currently commercialized and developing drug products for pain management are reviewed with respect to dosage form design as well as clinical efficacy. The drug delivery systems reviewed herein represent advanced formulation designs that are substantially improving analgesic drug therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18302030     DOI: 10.1080/03639040701542200

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  3 in total

Review 1.  A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs.

Authors:  Charles E Argoff; Daniel I Silvershein
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

2.  Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets.

Authors:  Stuart McLean; Raimondo Bruno; Susan Brandon; Barbara de Graaff
Journal:  Harm Reduct J       Date:  2009-12-22

3.  Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.